Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer did not improve their survival but did increase their risk of blood clots, according to a new study.
Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer did not improve their survival but did increase their risk of blood clots, according to a new study.